The oral GLP-1 Wegovy pill (why people are asking about it) A major recent development is the emergence of a pill-form GLP-1 option associated with Wegovy
"The new oral semaglutide trial adds to our evidence for treatment options for obesity," said Spaniolas, who is also the director of the Stony Brook bariatric and metabolic weight loss center
vitamin D intake ~20% of recommendations Lean mass risk: protein + calcium insufficiency may contribute, alongside other drivers B-vitamins: thiamine and cobalamin deficits appear to increase over time Clinical takeaway (my approach): GLP-1s dont cause malnutrition in everyone but they can unmask risk in the wrong context (older adults, low-protein diets, restrictive eating patterns, prolonged nausea/vomiting, rapid weight loss, post-bariatric patients)
Most athletes wait until after the workout to address recovery, but that approach leaves performance on the table
This increased oversight, while disruptive to compounders, ultimately benefits consumers by raising quality standards across the industry
Journaling: If you are not sure about the time or day you want to schedule for semaglutide administration, journaling is the way to go